Aequus Pharmaceuticals Inc.

C$0.01As of Sun 8 Nov 2026, 12:00 UTC
TSXV:AQSHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (33.86%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.30)
PE TTM —
TSR TTM —
Mkt cap C$0.663M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0064
28.56%
(41.24%)
Sell 6|0|3|6|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
19.66%
19.58%
17.78%
30.06%
Revenue$M
0.036
0.038
0.037
0.038
5.22%
8.36%
8.72%
8.24%
Peers (US$0.469M)
Cap (US$)
PE
0.527M
—
0.475M
—
Capital
TTM
5Y
10Y
Leveragex
1.502
—
—
EBIT/Intx
2.660
0.135
0.129
Own earn%
49.28
3.02
44.50
Sh yield%
36.01
17.56
18.19
Owners
Insiders/Inst%
10.92
87.27
Short interest%
1.60
SBC / revenue%
0.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
0–3
$1 testx
0.0
Incr. ROIC%
7